Annual EBITDA
$804.45M$124.17M-13.37%
Summary
- Current Value
- As of today, CRL annual EBITDA is $804.45M, down -13.37% on
- Historical Performance
- CRL annual EBITDA is down -15.89% over the past 3 years, up +15.93% over the past 5 years
- All-Time High Comparison
- CRL annual EBITDA is currently -17.51% below its historical high of $975.26M set on
- 3-Year Low Comparison
- CRL annual EBITDA is at its 3-year low
- Sector Comparison
- CRL annual EBITDA is higher than 92.29% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $804.45M | -13.4% | -15.9% | +15.9% | +239.0% | |
| Quarterly EBITDA | $294.11M | +24.5% | +19.3% | +26.0% | +401.7% | |
| TTM EBITDA | $896.17M | -1.3% | -8.2% | +6.0% | +235.9% | |
| Price | $314.32 | +93.9% | +65.0% | -17.3% | +1010.3% | |
| PE Ratio | 348.39 | – | +1587.9% | +609.8% | – | |
| Annual Revenue | $4.02B | -0.8% | +1.0% | +37.3% | +254.3% | |
| Annual EPS | -$2.91 | -1560.5% | -130.7% | -140.5% | +45.9% | |
| $401.14M | -29.2% | -38.5% | -12.6% | +179.2% | ||
| Annual Net Income | -$142.16M | -662.1% | -128.9% | -138.9% | +57.5% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $975.26M | -17.5% | |
| 5Y | $975.26M | -17.5% | |
| All | $975.26M | -17.5% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $804.45M | at low | |
| 5Y | $693.88M | N/A | +15.9% |
| All | $37.67M | +2035.5% |
EBITDA History
FAQ
- What is the current annual EBITDA of CRL?
- As of today, CRL annual EBITDA is $804.45M
- What is 1-year change in CRL annual EBITDA?
- CRL annual EBITDA is down -13.37% year-over-year
- What is 3-year change in CRL annual EBITDA?
- CRL annual EBITDA is down -15.89% over the past 3 years
- How far is CRL annual EBITDA from its all-time high?
- CRL annual EBITDA is currently -17.51% below its historical high of $975.26M set on December 31, 2023
- How does CRL annual EBITDA rank versus sector peers?
- CRL annual EBITDA is higher than 92.29% of companies in Healthcare sector
- When is CRL next annual earnings release?
- The next annual earnings release for CRL is on
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
$294.11M$76.57M+35.20%
Summary
- Current Value
- As of today, CRL quarterly EBITDA is $294.11M, up +35.20% on
- Historical Performance
- CRL quarterly EBITDA is up +24.49% year-over-year, up +19.28% over the past 3 years
- All-Time High Comparison
- CRL quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- CRL quarterly EBITDA is +57.09% above its 3-year low of $187.23M reached on
- Sector Comparison
- CRL quarterly EBITDA is higher than 92.40% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $294.11M | +35.2% | +24.5% | +19.3% | +26.0% | |
| Annual EBITDA | $804.45M | – | -13.4% | -15.9% | +15.9% | |
| TTM EBITDA | $896.17M | +6.9% | -1.3% | -8.2% | +6.0% | |
| Price | $314.32 | +7.8% | +93.9% | +65.0% | -17.3% | |
| PE Ratio | 348.39 | – | – | +1587.9% | +609.8% | |
| Quarterly Revenue | $982.73M | -2.1% | -2.2% | -4.3% | +9.7% | |
| Quarterly EPS | $6.86 | +10000.0% | +522.6% | +304.8% | +241.8% | |
| $221.85M | +47.7% | +46.8% | +32.3% | +34.7% | ||
| Quarterly Net Income | $334.44M | +10000.0% | +502.0% | +280.0% | +218.0% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $294.11M | at high | |
| 3Y | $294.11M | at high | |
| 5Y | $294.11M | at high | |
| All | $294.11M | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $187.23M | +57.1% | |
| 3Y | $187.23M | +57.1% | |
| 5Y | $187.23M | +57.1% | |
| All | $18.26M | +1510.7% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of CRL?
- As of today, CRL quarterly EBITDA is $294.11M
- What is CRL quarterly EBITDA most recent change?
- CRL quarterly EBITDA was up +35.20% on September 26, 2026
- What is 1-year change in CRL quarterly EBITDA?
- CRL quarterly EBITDA is up +24.49% year-over-year
- How far is CRL quarterly EBITDA from its all-time high?
- CRL quarterly EBITDA is currently at its all-time high
- How does CRL quarterly EBITDA rank versus sector peers?
- CRL quarterly EBITDA is higher than 92.40% of companies in Healthcare sector
- When is CRL next earnings release?
- The next earnings release for CRL is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
$896.17M$57.86M+6.90%
Summary
- Current Value
- As of today, CRL TTM EBITDA is $896.17M, up +6.90% on
- Historical Performance
- CRL TTM EBITDA is down -1.25% year-over-year, down -8.15% over the past 3 years
- All-Time High Comparison
- CRL TTM EBITDA is currently -8.84% below its historical high of $983.08M set on
- 3-Year Low Comparison
- CRL TTM EBITDA is +6.90% above its 3-year low of $838.31M reached on
- Sector Comparison
- CRL TTM EBITDA is higher than 91.53% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $896.17M | +6.9% | -1.3% | -8.2% | +6.0% | |
| Annual EBITDA | $804.45M | – | -13.4% | -15.9% | +15.9% | |
| Quarterly EBITDA | $294.11M | +35.2% | +24.5% | +19.3% | +26.0% | |
| Price | $314.32 | +7.8% | +93.9% | +65.0% | -17.3% | |
| PE Ratio | 348.39 | – | – | +1587.9% | +609.8% | |
| TTM Revenue | $3.98B | -0.6% | -1.2% | -5.7% | +16.1% | |
| TTM EPS | $0.90 | +118.6% | +158.0% | -90.2% | -88.3% | |
| $611.19M | +13.1% | +27.2% | -8.0% | +4.2% | ||
| TTM Net Income | $42.59M | +118.0% | +153.5% | -91.1% | -89.4% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $907.49M | N/A | -1.3% |
| 3Y | $975.66M | N/A | -8.2% |
| 5Y | $983.08M | -8.8% | |
| All | $983.08M | -8.8% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $838.31M | +6.9% | |
| 3Y | $838.31M | +6.9% | |
| 5Y | $838.31M | +6.9% | |
| All | $20.99M | +4169.3% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of CRL?
- As of today, CRL TTM EBITDA is $896.17M
- What is CRL TTM EBITDA most recent change?
- CRL TTM EBITDA was up +6.90% on September 26, 2026
- What is 1-year change in CRL TTM EBITDA?
- CRL TTM EBITDA is down -1.25% year-over-year
- How far is CRL TTM EBITDA from its all-time high?
- CRL TTM EBITDA is currently -8.84% below its historical high of $983.08M set on June 25, 2022
- How does CRL TTM EBITDA rank versus sector peers?
- CRL TTM EBITDA is higher than 91.53% of companies in Healthcare sector
- When is CRL next earnings release?
- The next earnings release for CRL is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- CRL Official Website www.criver.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1100682/000110068226000022/0001100682-26-000022-index.htm
- CRL Profile on Yahoo Finance finance.yahoo.com/quote/CRL
- CRL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/crl
